Genomic Expression, Inc.
PrivateLast Round
Seed
Nov 15, 2024
Total Funding Raised
$8.42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomic Expression, Inc. is a biotechnology company that provides RNA-based diagnostic services and develops AI-driven platforms for personalized cancer treatment and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomic Expression, Inc. Comparables
Compare Genomic Expression, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cofactor Genomics | 84% | |
| Rna Diagnostics Inc. | 79% | |
| BostonGene | 76% |
Genomic Expression, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 15, 2024 | ||||
| Crowdfunding | Nov 1, 2023 | ||||
| Convertible Debt | Nov 1, 2021 | ||||
| Seed | May 1, 2015 |
Key People
Founding team and executive leadership
Genomic Expression, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Innovation Fund Denmark | Grant |
| Pipeline Angels | Seed |
| Eurostars SME programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 181% MoM.
- Apr 2, 2026
Monthly visitors increased 76% MoM.
Genomic Expression, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genomic Expression, Inc.'s valuation, stock price, and market status.
Is Genomic Expression, Inc. a public or private company?
Genomic Expression, Inc. is a private company.
What is the current stock price of Genomic Expression, Inc.?
Genomic Expression, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Genomic Expression, Inc. worth (valuation)?
Valuation information for Genomic Expression, Inc. is not publicly available.
Can I buy Genomic Expression, Inc. stock?
Genomic Expression, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genomic Expression, Inc.'s last funding round?
Genomic Expression, Inc.'s most recent funding round was Seed on November 15, 2024.
Who are the main investors in Genomic Expression, Inc.?
Key investors in Genomic Expression, Inc. include National Cancer Institute, Innovation Fund Denmark, Pipeline Angels, Eurostars SME programme.
Will Genomic Expression, Inc. IPO soon?
No public IPO plans have been announced for Genomic Expression, Inc..
How can I track Genomic Expression, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomic Expression, Inc.'s secondary market activity and sign up for updates.